Analysis of Carlyle Secured Lending (NASDAQ:CGBD) and Orion Oyj (OTCMKTS:ORINY)


Orion Oyj (OTCMKTS:ORINYreceived rating) and Carlyle Secured Lending (NASDAQ:CGBDreceived rating) are both medical companies, but which one is the superior company? We’ll compare the two companies based on the strength of their analyst ratings, valuation, earnings, profitability, institutional ownership, risk, and dividends.

Analyst Recommendations

This is a breakdown of the most recent recommendations and price targets for Orion Oyj and Carlyle Secured Lending as reported by MarketBeat.com.

sell reviews keep ratings Buy reviews Strong buy recommendations rating score
Orion Oyj 0 0 0 0 N / A
Carlyle Secured Lending 0 1 0 0 2.00

Carlyle Secured Lending has a consensus price target of $15.00, suggesting a potential upside of 9.97%. Given the higher potential upside of Carlyle Secured Lending, analysts clearly believe Carlyle Secured Lending is cheaper than Orion Oyj.

Rating & Result

This table compares the revenue, earnings per share (EPS) and valuation of Orion Oyj and Carlyle Secured Lending.

gross receipts price/sales ratio net income earnings per share price-earnings ratio
Orion Oyj $1.23 billion 4.58 $229.29 million $0.80 25.00
Carlyle Secured Lending $171.24 million 4.18 $160.35 million $2.63 5.19

Orion Oyj has higher revenues and earnings than Carlyle Secured Lending. Carlyle Secured Lending is trading at a lower price-to-earnings ratio than Orion Oyj, suggesting that it is currently the cheaper of the two stocks.

profitability

This table compares the net margins, return on equity and return on total assets of Orion Oyj and Carlyle Secured Lending.

net margins return on equity return on investment
Orion Oyj 18.72% 27.56% 17.07%
Carlyle Secured Lending 87.20% 10.38% 4.61%

Risk & Volatility

Orion Oyj has a beta of 0.62, indicating its stock price is 38% less volatile than the S&P 500. In comparison, Carlyle Secured Lending has a beta of 1.67, indicating its stock price is 67% is more volatile than the S&P 500.

dividends

Orion Oyj pays an annual dividend of $0.49 per share and has a dividend yield of 2.5%. Carlyle Secured Lending pays an annual dividend of $1.28 per share and has a dividend yield of 9.4%. Orion Oyj pays out 61.3% of its profits in the form of a dividend. Carlyle Secured Lending pays out 48.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with profits for the next several years. Carlyle Secured Lending is clearly the better dividend stock due to its higher yield and lower payout ratio.

Institutional and Insider Ownership

23.2% of Carlyle Secured Lending shares are held by institutional investors. 0.5% of Carlyle Secured Lending shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers, and hedge funds believe a company will outperform the market over the long term.

summary

Carlyle Secured Lending beats Orion Oyj on 8 of the 14 factors compared between the two stocks.

About Orion Oyj

(received rating)

Orion Oyj develops, manufactures and markets human and veterinary medicines and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America and internationally. It offers prescription drugs and self-care products, including Nubeqa, for the treatment of prostate cancer; Dexdor and Precedex for critical care tranquilizers; Stalevo and Comtess/Comtan for Parkinson’s disease; Simdax for acute congestive heart failure; and Fareston, for breast cancer, and Salmeterol/Fluticasone Easyhaler, Budesonide/Formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler, for the treatment of asthma and chronic obstructive pulmonary disease. The Company also offers veterinary medicines including Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo and Tessie; and APIs for generic and proprietary drugs and contract manufacturing services. In addition, it markets and sells veterinary medicines manufactured by other international companies. The company supplies various healthcare providers and professionals such as specialist and general practitioners, veterinarians, pharmacies, hospitals, health centers, clinics and laboratories, as well as consumers with pets. Orion Oyj has partnered with Propeller Health to combine the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop novel bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.

About Carlyle Secured Lending

(received rating)

TCG BDC, Inc. is a business development company specializing in senior debt, senior secured loans, second senior secured loans, unsecured debt, mezzanine debt and equity investments. It specializes in direct investments. It specializes in medium-sized companies. It targets healthcare and pharmaceuticals, aerospace and defense, high-tech industries, business services, software, beverages, food and tobacco, hotel games and leisure, banking, finance, insurance and real estate sectors. The fund aims to invest in the United States of America, Luxembourg, the Cayman Islands, Cyprus and the United Kingdom. It invests in companies with between $25 million and $100 million in EBITDA.



Receive News & Reviews for Orion Oyj Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Orion Oyj and related companies with MarketBeat.com’s FREE daily email newsletter.

Comments are closed.